Weekly Rundown: Small-Cap Stocks with Upcoming Catalysts (June 9–13)

We've reviewed recent filings and company updates to highlight notable small-cap activity and upcoming investor events. Our aim is to provide timely insights to keep you informed and help you identify emerging opportunities. Here's what we're watching for the week of June 9–13.

Companies Participating at the Goldman Sachs 46th Annual Global Healthcare Conference (June 9–11, 2025):

ABCL ACRS ALEC ALLO AUTL BIOA

—-------------------------------------------------------------

BOLD ERAS ESPR FDMT HCAT IPHA

—-------------------------------------------------------------

LUNG MGNX MRSN NAUT PACB PRME

—---------------------------------------------------------------

RAPT RXRX SANA TERN TNGX VERV

—---------------------------------------------------------------

VIR ABSI FHTX MYGN

Companies Participating in the Oppenheimer 25th Annual Consumer Growth and E-Commerce Conference (June 9–11, 2025):

FIGS GRWG LCUT

Companies Participating in the Benzinga Cannabis Capital Conference (June 8–10, 2025, Chicago):

GRWG ISPR SHFS

Companies Presenting at the 30th Annual Congress of the European Hematology Association (EHA) (June 12–15, 2025, Milan, Italy):

IPHA: June 14 – Poster on IPH6501 NK cell engager in DLBCL & FL samples; preclinical combo with R-CHOP.

XFOR: June 12 – Poster on Phase 2 study of mavorixafor in chronic neutropenia (23-participant open-label trial).

BMEA: June 14 – Poster on BMF-500 safety, PK/PD, and activity in R/R AML, including FLT3m patients post-gilteritinib.

AUTL: June 13 & 15 – Two oral and one poster presentation; updated data from FELIX study of obe-cel in r/r B-ALL.

TERN: June 13 – Preclinical data on TERN-701 as potential treatment for chronic myeloid leukemia (CML).

KPTI: June 14 – Data on selinexor monotherapy in heavily pretreated myelofibrosis from Phase 2 XPORT-MF-035.

EDIT: June 14 – In vivo HSC data on HBG1/2 editing for sickle cell and beta thalassemia using proprietary HSC-tLNP.

SLN: TBA – Additional Phase 1 SANRECO study results of divesiran in PV accepted for oral presentation.

Other Companies with Key Catalysts This Week:

SNTI > Will participate in a Virtual Fireside Chat hosted by Chardan Capital Markets, LLC on Monday, June 9, 2025 at 3:00 PM ET.

TSHA > June 9–11 – Three oral & poster presentations on TSHA-102 in Rett syndrome + symposium on natural history data at IRSF Meeting in Boston.

ZENA > June 7–9 – VP of Corporate Development and CFO to participate in investor meetings at CEM Bermuda Capital Event 2025, held at Hamilton Princess & Beach Club.

KOPN > June 9–25 – Participating in Vision-Tech Roadshow with live demos of AR/VR systems, microdisplays & NeuralDisplay™ across medical, defense & training sectors.

LTRX > Will do live demos and daily giveaways of its LM4 AI-driven Out-of-Band Management (OOBM) platform at booth 3219 at Cisco Live held June 9–12, 2025, in San Diego.

JAGX > June 10 – CEO Lisa Conte to join virtual fireside chat at 9:00 AM ET during Lytham Partners’ Spring 2025 Spotlight Series, discussing orphan disease programs.

RBBN > Rosenblatt 5th Annual Technology Virtual Summit Tech Conference, June 10, 2025.

GRO > The Company will discuss these accomplishments with investors at the Wells Fargo Industrials Conference on June 10, 2025, in Chicago, Illinois.

IMUX > June 10–13 – Presenting preclinical data on IMU-838 at the 4th RSC Anglo-Nordic Medicinal Chemistry Symposium (Denmark); includes flash talk (FT18) and poster (P18) on broad-spectrum antiviral DHODH inhibitors. June 11 – Dr. Vitt and Ms. Breu to attend UBS Life Sciences Conference in London.

XHLD > June 10 – Live virtual presentation + investor 1x1s during Q2 Virtual Investor Summit, focused on small and microcap companies.

STAI > Scheduled participation in the 97th Annual American Association of Airport Executives (AAAE) Conference & Exposition, taking place June 8–10, 2025, in Atlanta, GA.

RPAY > June 10 – CEO John Morris & VP Damien Warner to host investor meetings at BMO Virtual Software Conference. June 11 – CEO John Morris to host investor meetings at Morgan Stanley US Financials Conference in New York.

WULF > June 10-11, 2025: Rosenblatt Annual Age of AI Summit, Virtual.

AXL > Will participate in the Deutsche Bank 2025 Global Auto Industry Conference on June 11.

NOTE > Three Part Advisors 2025 East Coast IDEAS Conference: Wednesday, June 11, 2025 at The Westin New York at Times Square in New York City. FiscalNote will provide a formal presentation and host investor meetings.

MCRP > Will participate in Sidoti's Small-Cap Virtual Conference, to be held on June 11-12, 2025.

XTIA > June 11 – Investor webinar at 4:15 PM ET hosted by RedChip, featuring CEO Scott Pomeroy discussing XTI’s VTOL TriFan 600 and regional air mobility strategy.

RYAM > June 11 – SVP Joshua Hicks to present and host 1x1 investor meetings at the 15th Annual East Coast IDEAS Investor Conference in NYC.

UIS > CEO Mike Thomson will present and meet with investors at the East Coast IDEAS Conference in New York City on June 11, 2025.

IPSC > The company will deliver two presentations at the EULAR 2025 Congress in Barcelona from June 11-14, highlighting data on its preclinical cell therapy pipeline and investigational programs for autoimmune diseases and cancer.

OSS > Participation in the upcoming NVIDIA GTC Paris Conference. The event will take place at the Paris Expo Porte de Versailles in Paris, France, on June 11–12, 2025.

CABA > The FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation to rese-cel for treating myositis, offering benefits like expedited BLA review and more frequent FDA interactions to support drug development. New clinical data from the RESET-Myositis, RESET-SLE™, and RESET-SSc™ trials will be presented in three oral sessions at the EULAR 2025 Congress in Barcelona, June 11-14.

FATE > Clinical and preclinical data from the Company's off-the-shelf cell therapy product platform will be featured at the European Alliance of Associations for Rheumatology European Congress of Rheumatology (EULAR 2025), being held in Barcelona, Spain on June 11-14, 2025.

PGEN > The Company will once again partner with the Recurrent Respiratory Papillomatosis Foundation (RRPF) to co-host the annual RRP Awareness Day on June 11, 2025, an international event that unites patients, caregivers, and healthcare professionals to raise awareness and foster community around this rare chronic disease.

OVID > The company will host an investor and media event on Thursday, June 12, 2025, from 9:30 to 10:30 am ET at its New York Hudson Yards headquarters, focusing on the strategic use of biomarkers in epilepsy to showcase the pharmacodynamic activity of its OV329 clinical program. Dr. Alexander Rotenberger, a leading expert, will join management to discuss biomarker applications in anti-seizure medicine research. The event will also be webcast live.

BCTX > The Company will be conducting a virtual investor presentation on Thursday, June 12.

SES > Dr. Qichao Hu, Founder and CEO, will participate in a Fireside Chat at the upcoming Deutsche Bank 2025 Global Auto Industry Conference taking place Thursday, June 12, 2025.

BRLT > The Company will participate in the 15th Annual East Coast IDEAS Investor Conference at The Westin Times Square in New York, NY. On June 12, 2025, management will host a fireside chat at 2:45 p.m. ET and hold investor meetings throughout the day.

RSKD > 1st Annual D.A. Davidson Consumer & Technology Conference in Nashville on Tuesday, June 10th, at 2:00 PM ET.

SGBX > The Company signed a non-binding Letter of Intent (LOI) to acquire Giant Containers Inc., a leader in modular, container-based infrastructure solutions. The acquisition is subject to due diligence, final agreements, board approvals, and regulatory clearances, with closing expected on or before June 15, 2025.

ADCT > Updated data to be shared during poster presentation at EHA2025 on Saturday, June 14.

PYPD > will host a conference call and webcast to report topline data for the SHIELD II Phase 3 trial, evaluating D-PLEX100 for the prevention of surgical site infections in patients undergoing abdominal colorectal surgery, on Monday, June 9, at 8:30 a.m. ET.

IMNN > will present at the Zacks SCR Life Sciences Virtual Investor Forum on Thursday, June 12, 2025.

SBC > Sidoti Small-Cap Virtual Conference Company Webcast on Wednesday, June 11, 2025. Zacks SCR Life Sciences Virtual Investor Forum Company Webcast on Thursday, June 12, 2025.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.